- Home
- KNSA vs BOH Comparison
KNSA vs BOH Comparison
Compare KNSA & BOH Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- KNSA
- BOH
- Stock Information
- Founded
- KNSA 2015
- BOH 1897
- Country
- KNSA United Kingdom
- BOH United States
- Employees
- KNSA N/A
- BOH N/A
- Industry
- KNSA Biotechnology: Pharmaceutical Preparations
- BOH Major Banks
- Sector
- KNSA Health Care
- BOH Finance
- Exchange
- KNSA Nasdaq
- BOH Nasdaq
- Market Cap
- KNSA 2.6B
- BOH 2.6B
- IPO Year
- KNSA 2018
- BOH N/A
- Fundamental
- Price
- KNSA $38.36
- BOH $65.39
- Analyst Decision
- KNSA Strong Buy
- BOH Hold
- Analyst Count
- KNSA 7
- BOH 6
- Target Price
- KNSA $49.71
- BOH $72.33
- AVG Volume (30 Days)
- KNSA 546.2K
- BOH 521.2K
- Earning Date
- KNSA 10-28-2025
- BOH 10-27-2025
- Dividend Yield
- KNSA N/A
- BOH 4.26%
- EPS Growth
- KNSA N/A
- BOH 22.78
- EPS
- KNSA 0.47
- BOH 4.09
- Revenue
- KNSA $597,973,000.00
- BOH $677,459,000.00
- Revenue This Year
- KNSA $62.63
- BOH $15.10
- Revenue Next Year
- KNSA $29.93
- BOH $7.76
- P/E Ratio
- KNSA $82.19
- BOH $16.05
- Revenue Growth
- KNSA 55.68
- BOH 8.56
- 52 Week Low
- KNSA $17.82
- BOH $57.45
- 52 Week High
- KNSA $42.05
- BOH $82.70
- Technical
- Relative Strength Index (RSI)
- KNSA 52.71
- BOH 54.68
- Support Level
- KNSA $36.56
- BOH $64.13
- Resistance Level
- KNSA $39.66
- BOH $65.88
- Average True Range (ATR)
- KNSA 1.58
- BOH 1.61
- MACD
- KNSA -0.13
- BOH 0.32
- Stochastic Oscillator
- KNSA 50.78
- BOH 83.04
About KNSA Kiniksa Pharmaceuticals Ltd.
Kiniksa Pharmaceuticals International PLC is a clinical-stage biopharmaceutical company focused on discovering, acquiring, developing, and commercializing therapeutic medicines for patients suffering from debilitating diseases. The company's clinical-stage product candidates include Rilonacept, abiprubart, and mavrilimumab.
About BOH Bank of Hawaii Corporation
Bank of Hawaii Corp provides a broad range of financial products and services predominantly to customers in Hawaii, Guam, and other Pacific Islands. The Bank's subsidiaries are engaged in equipment leasing, securities brokerage, investment advisory services, and providing credit insurance. It is organized into three business segments for management reporting purposes: Consumer Banking, Commercial Banking, and Treasury and Other. Majority of the revenue is generated from Consumer Banking segment which offers a broad range of financial products and services, including loan, deposit and insurance products; private banking and international client banking services; trust services; investment management; and institutional investment advisory services.